Press release
U.S. Hospitals Lead Adoption of Benign Prostatic Hypertrophy (BPH) Implant Devices Amid Rising Prevalence and Evolving Therapies
The Global Benign Prostatic Hypertrophy (BPH) Implant Devices Market is valued at US$ 70.2 million in 2025 and is projected to reach US$ 310.8 million by 2033, growing at a CAGR of 16.1% from 2025 to 2033. Market growth is driven by the increasing prevalence of benign prostatic hyperplasia among the aging male population, rising demand for minimally invasive treatment options, and continuous advancements in implant technologies.BPH implant devices are used to relieve urinary obstruction caused by prostate enlargement by mechanically opening the urethra without removing prostate tissue. The growing preference for minimally invasive therapies, supportive regulatory approvals, and expanding healthcare access are further accelerating market adoption. Increasing awareness, technological innovations, and rising healthcare investments continue to create significant opportunities for the global BPH implant devices market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/benign-prostatic-hypertrophy-implant-devices-market?sai-v
The Benign Prostatic Hypertrophy (BPH) Implant Devices Market involves medical devices designed to relieve urinary obstruction in men by widening the urethra and improving urine flow without major surgery.
Key Players :
=> key players in this market are Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, Richard Wolf Gmbh, Guangzhou Maya Medical Equipment.Co.ltd and Guangzhou Medunion Technologies Co.ltd
Key Developments
✅ April 2025: Teleflex Incorporated presented new clinical data on its UroLift System at a leading urology conference, demonstrating superior symptom relief and improved patient satisfaction compared to alternative BPH treatments. The findings reinforced the effectiveness of minimally invasive implants for long-term management of benign prostatic hypertrophy.
✅ February 2025: Zenflow Inc. completed pivotal clinical trials for its Spring Implant System, showing significant improvements in urinary symptom scores and flow rates. The positive results positioned the company for regulatory submission and upcoming commercialization.
✅ January 2025: Teleflex launched the UroLift 2 System with Advanced Tissue Control (ATC), enabling treatment across a wider range of prostate anatomies while improving precision and minimizing recovery time.
Recent Mergers & Strategic Moves
✅ March 2025: Boston Scientific Corporation expanded its urology device portfolio through strategic acquisitions and partnerships focused on minimally invasive and implantable technologies for BPH management.
✅ January 2025: Boston Scientific completed the USD 3.7 billion acquisition of Axonics Inc., enhancing its capabilities in urological implants and broadening its presence in the global benign prostatic hypertrophy devices market.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=benign-prostatic-hypertrophy-implant-devices-market?sai-v
Market Drivers - Benign Prostatic Hypertrophy (BPH) Implant Devices Market
Rising BPH Prevalence: Increasing cases among aging male populations drive device demand.
Minimally Invasive Preference: Growing shift toward less invasive treatments with faster recovery.
Technological Advancements: Introduction of innovative implants improving urinary flow and patient comfort.
Healthcare Spending Growth: Expanding access to advanced urological treatments in developed and emerging regions.
Awareness & Diagnosis: Increased awareness and early diagnosis of prostate conditions boost adoption rates.
Industry Developments - Benign Prostatic Hypertrophy (BPH) Implant Devices Market
Product Innovations: Launch of next-generation implants offering better efficacy and fewer complications.
Regulatory Approvals: FDA and CE clearances enabling wider commercial availability.
Strategic Collaborations: Partnerships among device manufacturers and healthcare institutions for product development and distribution.
Geographical Expansion: Market penetration into Asia-Pacific and Latin America through local partnerships.
Training Programs: Rising investment in physician training to improve procedural adoption.
Market Outlook - Benign Prostatic Hypertrophy (BPH) Implant Devices Market
The market is expected to witness steady growth as minimally invasive treatments gain traction, supported by an aging global population, continuous product innovation, and expanding healthcare infrastructure.
Key Segments:
➥ By Product Type: Prostatic Urethral Lift, Transurethral Resection of the Prostate (TURP), Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Others
➥ By End-User: Hospitals, Ambulatory Surgery Centers
Research Process:
Both primary and secondary data sources have been used in the Global Benign Prostatic Hypertrophy (BPH) Implant Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/benign-prostatic-hypertrophy-implant-devices-market?sai-v
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Hospitals Lead Adoption of Benign Prostatic Hypertrophy (BPH) Implant Devices Amid Rising Prevalence and Evolving Therapies here
News-ID: 4236060 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Carbon Capture and Sequestration Market to Grow at 13.5% CAGR, Led …
The global Carbon Capture and Sequestration Market is growing at a CAGR of 13.5% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, the US Department of Energy announced $6.5 billion in funding for CCS projects under the Bipartisan Infrastructure Law.
✅ In October 2025, Occidental Petroleum launched the world's largest direct air capture facility in Texas, capable of removing 1 million…
South Korea Beverage Packaging Industry Impact on Environment | Market Growth Co …
The South Korea Beverages Packaging Market size was worth USD 3,350.9 million in 2024 and is expected to show significant growth by reaching up to USD 4,796.9 million by 2033, growing at a CAGR of 4.52% during the forecast period 2024-2031. As Per the DataM intelligence Report.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/south-korea-beverages-packaging-market?oppratik
Recent Product Launch In South Korea -
✅ In…
United States Creator Economy Market to hit US$ 894.84 Billion By 2032 | Major C …
Market Size and Forecast:
Global Creator Economy Market reached US$ 212.32 billion in 2024 and is expected to reach US$ 894.84 billion by 2032, growing with a CAGR of 19.70% during the forecast period 2025-2032.
The global Creator Economy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
United States Carbon Capture & Storage Market to Grow at 15.95% CAGR, Driven by …
The global Carbon Capture & Storage Market is growing at a CAGR of 15.95% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, ExxonMobil announced a $7 billion investment to expand its CCS operations along the Gulf Coast, targeting 50 million tons of annual CO2 storage capacity.
✅ In October 2025, the US Department of Energy launched the Carbon Negative Shot initiative, aiming to…
More Releases for Prostatic
Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market?
The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58…
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market?
The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened…
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market?
The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened…
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market?
The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened…
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
